» Articles » PMID: 1663451

Senescence As a Mode of Tumor Suppression

Overview
Date 1991 Jun 1
PMID 1663451
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Two independent lines of experimental evidence are presented in support of the hypothesis that senescence is a normal mechanism of tumor suppression, a homeostatic device designed through evolution to limit cell proliferation irreversibly and thereby to protect the organism against cancer. One set of experiments uses normal human foreskin fibroblasts, transfected at early passage with SV40 DNA and subsequently infected with the K-ras virus. If the cells are immortal prior to infection, they become tumorigenic and make large tumors in nude mice, whereas if they are not immortal, though expressing SV40 T-antigen, they make tiny tumors that senesce in the test mouse after as many doublings as similar cells make in culture. This result demonstrates that immortalization is essential for progressive tumor growth in vivo. The second set of experiments demonstrate that normal human mammary epithelial cells can be immortalized by transfection with viral DNA from human papilloma virus 16 or 18, although these viruses have not been associated with breast cancer. The effective immortalization and other premalignant changes induced by human papilloma virus transfection are accompanied by chromosome changes that may contribute to the partially transformed phenotypes. None of the cloned or pooled transfectants have been tumorigenic in the nude mouse assay. Here, too, immortalization is experimentally separable from tumor-forming ability.

Citing Articles

A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.

Froney M, Cook C, Cadiz A, Flinter K, Ledeboer S, Chan B ACS Pharmacol Transl Sci. 2024; 7(9):2799-2819.

PMID: 39296266 PMC: 11406699. DOI: 10.1021/acsptsci.4c00251.


Senolytics and cell senescence: historical and evolutionary perspectives.

Finch C Evol Med Public Health. 2024; 12(1):82-85.

PMID: 38757096 PMC: 11097598. DOI: 10.1093/emph/eoae007.


Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma.

Tan J, Wang C, Jin Y, Xia Y, Gong B, Zhao Q Front Immunol. 2023; 14:1309138.

PMID: 38035110 PMC: 10687280. DOI: 10.3389/fimmu.2023.1309138.


UV-induced G4 DNA structures recruit ZRF1 which prevents UV-induced senescence.

De Magis A, Limmer M, Mudiyam V, Monchaud D, Juranek S, Paeschke K Nat Commun. 2023; 14(1):6705.

PMID: 37872164 PMC: 10593929. DOI: 10.1038/s41467-023-42494-x.


Senescent cells at the crossroads of aging, disease, and tissue homeostasis.

Kuehnemann C, Wiley C Aging Cell. 2023; 23(1):e13988.

PMID: 37731189 PMC: 10776127. DOI: 10.1111/acel.13988.


References
1.
Werness B, Levine A, Howley P . Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990; 248(4951):76-9. DOI: 10.1126/science.2157286. View

2.
Popescu N, DIPAOLO J . Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res. 1990; 50(4):1316-23. View

3.
Band V, Zajchowski D, Kulesa V, Sager R . Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A. 1990; 87(1):463-7. PMC: 53284. DOI: 10.1073/pnas.87.1.463. View

4.
Smith J . Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci U S A. 1988; 85(16):6042-6. PMC: 281901. DOI: 10.1073/pnas.85.16.6042. View

5.
Durst M, Boukamp P, Fusenig N, Gissmann L . Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1987; 1(3):251-6. View